Asahi Kasei’s forward osmosis–membrane distillation (FO–MD) system has been integrated by Japan’s Peptistar into its API trial production facility.
The heat- and pressure-free technology concentrates pharmaceutical solutions while preserving quality, reducing freeze-drying time and improving productivity.
The system is now being evaluated at manufacturing scale for GMP-compliant production.
Source link
Japan's Asahi Kasei advances API production with FO–MD system
By Saartaj
Related Posts
Russia's SIBUR launches HDPE grade for beverage closure caps
SIBUR has introduced HD21550 CC, a new bimodal high-density polyethylene grade for 38 mm beverage closure caps. Developed…
BySaartajGermany's Evonik secures methanol supply with new pipeline
Evonik has commissioned a new pipeline linking Lülsdorf and Wesseling in Germany to secure long-term methanol supply for…
BySaartajAuthentic, One Jeanswear partner for Lee in US & Canada
Authentic Brands Group (Authentic), a global brand development, marketing and entertainment platform, today announced a new long-term partnership…
BySaartajFrance’s TotalEnergies acquires 10% stake in Abu Dhabi's Bab Gas Cap
TotalEnergies has secured a 10 per cent interest in Abu Dhabi’s Bab Gas Cap Concession alongside ADNOC and…
BySaartajTrending Posts
Gallery